Why is wall street so calm in a seemingly world of crisis? 10/9/23
CNBC's "Fast Money"
00:00
Bristol Myers' Acquisition of Murati Therapeutics
This chapter discusses the announcement of Bristol Myers' acquisition of cancer drug maker Murati Therapeutics for up to $5.8 billion. The deal is seen as a way for Bristol Myers to offset expected revenue losses and boost their pipeline. However, shares of both companies fall, with Bristol Myers hitting a new 52-week low.
Play episode from 27:20
Transcript
